
The Analyst
Columbia Care is being acquired by Cresco Labs (OTC:CRBLF), in a deal set to close by year-end. In a research note published Thursday, Cantor Fitzgerald's Pablo Zuanic kept an overweight rating for (OTC:CCHWF) with a price target of $8.37.